Laurie Toich, Assistant Editor

Nanoparticles containing an allergen resets immune system.

A trial drug could offer hope for patients with primary sclerosing cholangitis.

KaloBios Pharmaceuticals plans to adopt a transparent and responsible pricing model for prescription drugs.

KaloBios Pharmaceuticals plans to adopt a transparent and responsible pricing model for prescription drugs.

Top news of the day from across the healthcare landscape.

Medication Reconciliation can improve patient safety in patients with complex prescription regimens.

Two new outcome studies for Jardiance will be conducted in patients with type 2 diabetes.

Warfarin is found to have low complication rates and low mortality rates.

Smokers taking Chantix/Champix have a higher quit rate and a decrease in neuropsychiatric adverse effects.

Epigenetic changes seen in HIV-positive patients can cause biologic aging.

Epigenetic changes seen in HIV-positive patients can cause biologic aging.

Top news of the day from across the healthcare landscape.

Cabometyx targets multiple tyrosine kinases involved in the development of renal cell carcinoma.

Cabometyx targets multiple tyrosine kinases involved in the development of renal cell carcinoma.

Disease management support programs help patients maintain medication adherence.

Infection concerns regarding allergy immunotherapy sparked by a recent outbreak of meningitis caused by contaminated spinal injections.

Neratinib plus paclitaxel did not improve outcomes in metastatic ERBB2-positive breast cancer.

Oropharyngeal and nonoropharyngeal cancers more prevalent in patients diagnosed with HCV.

Top news of the day from across the healthcare landscape.

Current CDC testing guidelines fall short of solving the problem of undiagnosed patients with hepatitis C.

Research may lead to new therapeutic strategies for treating allodynia.

Pharmacy benefit manager releases data showing the cost of insulin grew by 8%.

Reducing cancer cell’s access to LDL and LDL could prevent tumor growth.

Top news of the day from across the healthcare landscape.

YM155 combined with chemotherapy shows promise reducing retinoblastoma cells and tumors in mouse models.

Patients receiving nucleos(t)ide analogue treatment for HBV have a lower risk of developing hepatocellular carcinoma and cirrhosis.

Expanded Medicaid coverage could lead to reduced long-term healthcare costs.

Study shows that the current hepatitis delta treatment is still effective, but researchers feel advancements could be made.

By manipulating HuR, researchers are able to kill drug resistant pancreatic cancer cells.

Metformin has been found the most effective type 2 diabetes drug.